Funding Received
$4.5 Million in 1 Round from 2 Investors
Most Recent Funding
$4.5 Million on March 19, 2014 / Undisclosed Round
Headquarters:
Birmingham, AL
Description:
Gem Pharmaceuticals, LLC, is a clinical-stage biopharmaceutical company developing proprietary anthracycline derivatives specifically
Categories:
Biotechnology
Website:
http://gempharmaceuticals.com

Detailed Description

Update

Gem Pharmaceuticals, LLC, is a clinical-stage biopharmaceutical company developing proprietary anthracycline derivatives specifically designed to eliminate the critical cardiotoxicity side effect of this powerful class of chemotherapeutics while maintaining their well-documented anti-cancer efficacy.

Current Team (3)

Update

Funding Rounds (1) - $4.5M

Update

Offices/Locations (1)

Update
  • Office

    941 Lake Forest Circle

    Birmingham, AL 35244

    USA

Images (1)

Update
  • 2289e2d0b2621feaf8151220be3c690e